Navigation Links
MiMedx to Present at Jefferies 2013 Global Healthcare Conference
Date:5/28/2013

KENNESAW, Ga., May 28, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the Jefferies 2013 Global Healthcare Conference in New York.  Parker H. "Pete" Petit, Chairman and CEO and Michael J. Senken , Chief Financial Officer, are scheduled to present on June 3, 2013 at 1:30 p.m. Eastern Daylight Time. A webcast of this presentation will be available on the Company's website, www.mimedx.com

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary Purion® Process, to produce a safe, effective and minimally manipulated implant for homologous use. MiMedx® is the leading supplier of amniotic tissue, having supplied over 150,000 allografts to date to distributors and OEMs for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare.


'/>"/>
SOURCE MiMedx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America
2. MiMedx Announces Record First Quarter 2013 Results
3. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
4. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
5. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
6. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
7. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
8. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
9. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
10. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
11. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Calif. , Jan. 17, 2017  Protagonist ... announced that it has initiated a global Phase ... an oral peptide that targets alpha4beta7 integrin. The ... study is to evaluate the safety/tolerability and efficacy ... patients with moderate to severe active disease. ...
(Date:1/16/2017)... Morrisville, NC (PRWEB) , ... January 16, 2017 ... ... science company, received the prestigious Tibbetts Award from the U.S. Small Business ... participants “that have created a significant economic or social impact […] and are considered ...
(Date:1/13/2017)... DUBLIN , Jan 13, 2017 Research ... by Product, Manufacturing, Application - Global Forecast to 2021" report ... ... by 2021 from USD 3.39 Billion in 2016, at a CAGR ... on the basis of product, manufacturing type, and application. Factors such ...
(Date:1/13/2017)... Island, NY (PRWEB) , ... January 13, 2017 ... ... teamed up with several companies to offer its customers three new solutions for ... probe would come in handy if a customer has an oddly-shaped sample that ...
Breaking Biology Technology:
(Date:12/16/2016)... Dec 16, 2016 Research and Markets has ... - Global Forecast to 2021" report to their offering. ... The biometric vehicle ... at a CAGR of 14.06% from 2016 to 2021. The market ... projected to reach 854.8 Million by 2021. The growth of the ...
(Date:12/15/2016)... Germany , December 15, 2016 ... provider, today announced an agreement with NuData Security, an ... forces. The partnership will enable clients to focus on good ... local data protection regulation. ... In order to provide a one-stop fraud ...
(Date:12/15/2016)... 2016 ... Research and Markets has announced the addition of the ... The report forecasts the global military biometrics market to grow at ... report has been prepared based on an in-depth market analysis with inputs ... prospects over the coming years. The report also includes a discussion of ...
Breaking Biology News(10 mins):